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Edinburgh EH8 9XD, Scotland, United Kingdom
Protein S-palmitoylation, the reversible thioester linkage of
a 16-carbon palmitate lipid to an intracellular cysteine residue,
is rapidly emerging as a fundamental, dynamic, and wide-
spread post-translational mechanism to control the properties
and function of ligand- and voltage-gated ion channels. Palmi-
toylation controls multiple stages in the ion channel life cycle,
from maturation to trafficking and regulation. An emerging
concept is that palmitoylation is an important determinant of
channel regulation by other signaling pathways. The elucida-
tion of enzymes controlling palmitoylation and developments
in proteomics tools now promise to revolutionize our under-
standing of this fundamental post-translational mechanism in
regulating ion channel physiology.
Protein S-palmitoylation, the most common form of pro-
tein S-acylation identified over 30 years ago (1), involves the
addition of a 16-carbon chain palmitic acid, via a hydroxyl-
amine-sensitive thioester linkage, to intracellular cysteine
residues. Importantly, protein palmitoylation is a reversible
post-translational modification (Fig. 1a) and, unlike other
irreversible lipid modifications such as myristoylation and
prenylation, thus represents a dynamic mechanism to spatio-
temporally control protein function and interactions (for re-
views, see Refs. 2–10). Indeed, dysregulation of protein palmi-
toylation results in a number of major disorders, including
cancer, X-linked mental retardation, and schizophrenia (11–
17), emphasizing the importance of this post-translational
modification (PTM)2 in normal physiology and disease. Re-
cent advances in proteomics approaches to characterize pro-
tein palmitoylation and the identification of the enzymes that
control palmitoylation (palmitoyl acyltransferases and zDH-
HCs (zinc finger- and DHHC domain-containing proteins))
and depalmitoylation (palmitoyl thioesterases) have revealed
the central role of palmitoylation in controlling a diverse array
of proteins, including an ever-expanding number of ion chan-
nels (see Tables 1–3).
The addition of palmitic acid increases the hydrophobicity
of a protein and thus may affect ion channel function in mul-
tiple ways. Evidence suggests that protein S-palmitoylation
controls many stages in the life cycle of ion channels (Fig. 1b).
Palmitoylation-dependent Control of Ion Channels:
From Assembly to Regulation
A diverse array (40) of pore-forming and regulatory sub-
units of ion channels have been experimentally identified as
being palmitoylated, ranging from the virally encoded M2
channel to voltage- and ligand-gated ion channels involved in
complex behaviors (Tables 1–3). Both surface expression and
intrinsic activity/regulation of ion channels can be controlled
by palmitoylation of cognate pore-forming and/or regulatory
subunits. Although the focus of this minireview is palmitoyla-
tion-dependent regulation of ion channel subunits per se, it is
important to consider that palmitoylation also controls many
adaptor and cell signaling proteins (for example, PSD-95,
AKAP18, G-proteins, etc. (5)) that control macromolecular
ion channel complexes.
Control of Channel Cell-surface Expression and Spatial
Organization
The surface expression of a channel is dependent upon the
delicate balance between channel synthesis, forward traffick-
ing to the membrane and subsequent internalization, recy-
cling, and degradation. Palmitoylation plays a significant role
in controlling channel cell-surface expression and clustering
by acting at distinct stages of the trafficking pathway. For sev-
eral channels, including voltage-gated sodium (Nav1.2) (18)
and potassium (Kv1.5) (19) channels, palmitoylation is
thought to occur very early in the biosynthetic pathway and to
regulate channel maturation/quality control. Indeed, palmi-
toylation regulates the formation of ligand-binding sites in
nicotinic acetylcholine receptors (20, 21). Palmitoylation of a
cluster of C-terminal cysteines in the pore-forming NR2A
subunit of NMDA receptors (22) and a cysteine residue juxta-
posed to the M2 membrane domain in the GluR1 subunit of
AMPA receptors (23) controls Golgi retention of the respec-
tive channel, whereas palmitoylation of the intracellular N-
terminal S0-S1 loop of large conductance calcium- and volt-
age-activated potassium (BK) channels modulates but is not
essential for cell-surface delivery (24). Palmitoylation also
controls the spatial organization of channels once at the
plasma membrane as illustrated by the formation of orthogo-
nal arrays of AQP4 (aquaporin-4) channels controlled by
palmitoylation of two C-terminal cysteine residues (25, 26),
whereas C-terminal palmitoylation promotes association of
P2X7 (P2X purinoceptor 7) receptors with cholesterol-rich
microdomains (“lipid rafts”) (27). Furthermore, synaptic clus-
tering of GABAA receptors is controlled by palmitoylation of
an intracellular loop of the 2 subunit (28). Agonist-induced
internalization of AMPA receptors is determined by palmi-
toylation of a single cysteine residue in GluR1 and GluR2 sub-
units, distinct from that controlling Golgi retention (23, 29,
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30). Palmitoylation also controls internalization of Kv1.5
channels, as palmitoylation-deficient Kv1.5 channels display a
reduced internalization rate with consequently higher surface
expression (19, 31).
Palmitoylation of regulatory subunits and adaptor proteins
is also an important determinant of channel surface delivery
and stability. For example, surface expression of the voltage-
gated potassium channel Kv4.3 is intimately controlled by
palmitoylation of the regulatory KChip2 and KChip3 subunits
(32), whereas NMDA and AMPA receptor trafficking is con-
trolled by palmitoylation of a number of scaffolding proteins
such as PSD-95 (33–35), Delphilin (36), and GRIP1b (37, 38).
Control of Channel Activity at the PlasmaMembrane:
Cross-talk with Other PTMs
Relatively few studies have revealed the effects of palmitoy-
lation on the intrinsic activity and/or gating kinetics of ion chan-
nels. Palmitoylation of the voltage-sensitive potassium channel
FIGURE 1. Reversible protein palmitoylation and regulation of the ion channel life cycle. a, schematic illustrating reversible protein palmitoylation.
Palmitoylation is controlled by a family of acyl palmitoyltransferases (zDHHCs), and depalmitoylation is controlled by a limited number of thioesterases.
b, palmitoylation controls multiple steps in the life cycle of an ion channel that include assembly (step 1), maturation (step 2), control of Golgi exit/sorting
(step 3) and trafficking (step 4), insertion in the plasmamembrane (step 5), clustering and localization in membrane microdomains (step 6), determination of
activity regulation by other signaling pathways (step 7), internalization (step 8), recycling (step 9), and degradation (step 10).
TABLE 1
Ligand gated-ion channels
Common channel abbreviations and subunit as well as gene names are given. “-ome” indicates that that subunit has also been identified in mammalian palmitoylome
screens (73, 75, 79, 85, 86). “candidate cysteine” indicates experimentally determined cysteine residues (shaded boxes) with flanking 10 amino acids. The predicted
membrane domain is underlined. Amino acid numbering corresponds to the NCBI murine accession number given for consistency. “Y” indicates that at least one
cysteine within the corresponding candidate cysteine sequence is predicted using the CSS-Palm 2.04 algorithm (67) at high threshold using the corresponding accession
number of the full-length murine channel-coding sequence (also validated for cognate species used in reference). “N” indicates that cysteines in the candidate sequence
are not predicted. An asterisk indicates that alternative cysteines are predicted in the coding sequence. “location” indicates the predicted location in the channel subunit.
“after” or “before” the membrane domain indicates palmitoylated cysteine within 10 amino acids of a membrane domain. nAChR, nicotinic acetylcholine.
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Kv1.1 (39), within the intracellular linker between transmem-
brane domains 2 and 3, increases the intrinsic voltage sensitivity
of the channel. Palmitoylation of the  subunit of epithelial so-
dium channels also affects channel gating (40), whereas the pal-
mitoylated regulatory 2a subunit of N-type calcium channels
controls voltage-dependent inactivation (41, 42).
In contrast, an emerging concept is that palmitoylation is
an important determinant of ion channel regulation by other
PTMs. Indeed, 15 years ago, palmitoylation of the GluR6 sub-
unit of kainate receptors was reported to reduce channel
phosphorylation by PKC (43). Similarly, palmitoylation inhib-
its PKC-mediated phosphorylation of the GluR1 subunit of
AMPA receptors, which is important for receptor insertion
(29). In both cases, the mechanism likely results from steric
hindrance, as the palmitoylated cysteine is immediately adja-
cent to the consensus phosphorylation site analogous to that
hypothesized for palmitoylation-dependent regulation of 2-
adrenergic receptor phosphorylation (44, 45). However,
palmitoylation can also promote channel phosphorylation.
Fyn-dependent tyrosine phosphorylation of the NR2A sub-
unit of NMDA receptors, at a site juxtaposed between the M4
membrane-spanning helix and a cluster of palmitoylated cys-
teine residues, is abrogated upon site-directed mutation of the
palmitoylated cysteines (22). This palmitoylation-dependent
enhancement of tyrosine phosphorylation inhibits internaliza-
tion of the NMDA receptor (22).
A novel mechanism for cross-talk between palmitoylation
and phosphorylation, through regulation of membrane associ-
ation of an intracellular channel domain, has been revealed in
BK channels (46). In this system, palmitoylation of a dicys-
teine motif in the alternatively spliced C-terminal STREX
(stress-regulated exon) insert promotes association of the
STREX domain with the plasma membrane. PKA-dependent
phosphorylation of a serine residue immediately upstream of
the palmitoylated cysteines results in dissociation of the
STREX domain from the plasma membrane, leading to chan-
nel inhibition. The reciprocal control of membrane associa-
tion of a protein domain by these PTMs likely represents a
common mechanism in other signaling proteins. For example,
the PDE10A (phosphodiesterase 10A) splice variant is tar-
geted to the plasma membrane via palmitoylation of an alter-
natively spliced N-terminal insert. PKA phosphorylation of
the spliced insert, adjacent to the palmitoylated cysteine resi-
due, results in dissociation of the PDE10A variant from the
plasma membrane (47).
Palmitoylation also determines regulation by other signal-
ing pathways. G-protein (Gq)-mediated stimulation of N-type
calcium channels is conferred by the palmitoylated N termi-
nus of the regulatory 2a subunit splice variant acting as a
steric inhibitor of an arachidonic acid-binding domain (48–
50). In the presence of non-palmitoylated regulatory  sub-
units, Gq-mediated signaling, via arachidonic acid, inhibits
calcium channel activity. A potentially important but as yet
unexplored mechanism for cross-talk is palmitoylation-de-
pendent control of cysteine reactivity per se upon thioester
addition of palmitate to a target cysteine. Indeed, cysteine
residues often form disulfide cross-bridges, or their free sulf-
hydryl groups are targets for both redox as well as S-nitrosyla-
tion pathways, all of which are important ion channel
regulators.
Location of Palmitoylated Cysteine Is Important for Function
The functional effect of palmitoylation is dependent on
both the channel type and the location of the palmitoylated
cysteine residue within a given channel subunit. In both li-
gand-gated (e.g. AMPA and NMDA) and voltage-gated (e.g.
BK) channels, palmitoylation of discrete sites on the same
channel subunit can exert fundamentally distinct effects. For
example, palmitoylation of the C-terminal cluster of cysteine
residues in NR2A and NR2B controls Golgi retention,
whereas palmitoylation of the cysteine cluster proximal to the
M4 transmembrane domain controls channel internalization
(22). In BK channels, palmitoylation of the N-terminal intra-
cellular S0-S1 linker controls surface expression (24), whereas
inclusion of an alternatively spliced insert (STREX) in the cy-
tosolic C terminus determines channel regulation by PKA-de-
pendent phosphorylation (46). Such data raise several funda-
mental questions regarding both the mechanistic basis for
regulation of channel properties by palmitoylation and how
distinct sites on the same protein may be differentially
palmitoylated.
Mechanistically, it is generally assumed that palmitoylation
facilitates membrane association. However, although exploi-
tation of fluorescent fusion proteins encoding the entire cyto-
solic C terminus of BK channels supports such a mechanism
(46), direct experimental evidence is lacking for most chan-
nels. Importantly, the addition of palmitic acid can modify
protein hydrophobicity. Thus, palmitoylation may also con-
trol structural conformation, as well as protein-protein inter-
actions, independently of membrane association especially
where the palmitoylated cysteine is juxtaposed to a membrane
domain (2–10). Little is known about which of the potential
palmitoyl acyltransferases (gene family zDHHC) control ion
channel palmitoylation, although analysis of both NMDA (22)
and BK (51) channels has suggested that distinct palmitoy-
lated domains on the same polypeptide can be regulated by
different zDHHCs.
Mechanisms Controlling and Tools Available to
Investigate Ion Channel Palmitoylation
It has been more than 20 years since the first palmitoylated
ion channels were discovered (18, 52). The recent develop-
ment of new bioinformatics and proteomics tools, together
with the identification of zDHHCs, is starting to revolutionize
our understanding of ion channel palmitoylation.
Identification of Palmitoyl Acyltransferases and Acyl
Thioesterases
Although autoacylation of some cysteine-containing pep-
tides/proteins in the presence of palmitoyl-CoA has been re-
ported (9), the recent discovery of a large family (at least 23
members in mammals) of candidate palmitoyl acyltrans-
ferases suggests that protein palmitoylation is predominantly
an enzymatic process from yeast to man (2, 3, 5–10). These
predicted transmembrane zinc finger-containing proteins
include a conserved Asp-His-His-Cys (DHHC) signature se-
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quence within a cysteine-rich stretch of50 amino acids that
is critical for catalytic activity (53), with palmitoylation pro-
ceeding via a two-step mechanism (54). Although no “consen-
sus” motif for protein palmitoylation has been identified, in-
creasing evidence suggests that zDHHCs can display substrate
specificity for proteins, including ion channels (22, 55), al-
though the mechanisms involved are poorly characterized. In
this regard, although many zDHHCs are thought to be local-
ized to the endoplasmic reticulum/Golgi, largely based on
overexpression studies, the subcellular localization of both
native zDHHCs and ion channel palmitoylation is poorly
characterized. Cysteine palmitoylation is dependent on three
main factors: (i) the local concentration of fatty acyl-CoA that
can be increased near hydrophobic environments (56), (ii)
localization with the zDHHCs found on membranes (5, 53),
and (iii) cysteine reactivity that can typically be enhanced by
proximity to basic or hydrophobic residues (56–58). Thus, an
initial membrane association signal is likely required to allow
efficient palmitoylation. In30% of identified channel sub-
units, the palmitoylated cysteine is within 10 amino acids of a
membrane domain (Tables 1 and 2). However, in the majority
of channels, this is not the case, suggesting that additional
initiating membrane association signals are required adjacent
to the site of palmitoylation. Likely candidates include regions
of basic charge (59), observed in30% of palmitoylated chan-
nels such as the STREX variant of the BK channel (46), hydro-
phobic domains, and other lipid anchors.
The regulation of zDHHC activity is poorly character-
ized. Activity-dependent redistribution of zDHHC2 in neu-
rons (60) controls palmitoylation of the postsynaptic scaf-
folding protein PSD-95, regulating NMDA receptor
function. Furthermore, zDHHCs express a range of pro-
tein-protein interaction domains and potential sites for
PTMs, including phosphorylation and palmitoylation, sug-
gesting multiple mechanisms for zDHHC regulation (5).
Intriguingly, as ion channels themselves determine cellular
excitability, this may provide a local feedbackmechanism to reg-
ulate palmitoylation status. zDHHCs are also reported to assem-
ble selectively with a number of ion channels, including GABAA
(61) and BK (51) channels, suggesting that channels and palmi-
toylating enzymesmay exist within multimolecular signaling
complexes.
To date, enzymes responsible for depalmitoylation of ion
channels, as for most other palmitoylated membrane pro-
teins, have not been clearly defined. The cytosolic protein
APT1 (acyl-protein thioesterase-1) (62, 63) and the re-
cently characterized protein APT2 (64), as well as PPT1
(palmitoyl-protein thioesterase-1) and PPT2, are likely
candidates. However, PPT1 is expressed predominantly in
lysosomes (65) and is thus most likely responsible for de-
palmitoylation of channels undergoing degradation. The
development of specific APT1 inhibitors (66) should begin
to reveal insights into the role of depalmitoylation in con-
trolling ion channels.
Palmitoylation Site Prediction
In contrast to many PTMs, no canonical consensus site for
protein palmitoylation has been characterized. However, sev-
TABLE 2
Voltage-gated and other ion channels
Common channel names and subunit as well as gene names are given. “-ome” indicates that that subunit has also been identified in mammalian palmitoylome screens
(73, 75, 79, 85, 86). “candidate cysteine” indicates experimentally determined cysteine residues (shaded boxes) with flanking 10 amino acids. The predicted
transmembrane domain is underlined. Amino acid numbering corresponds to the NCBI murine accession number given for consistency. “Y” indicates that at least one
cysteine within the corresponding candidate cysteine sequence is predicted using the CSS-Palm 2.04 algorithm (67) at high threshold using the corresponding accession
number of the full-length murine channel-coding sequence (also validated for cognate species used in reference). “N” indicates that cysteines in the candidate sequence
are not predicted. An asterisk indicates that alternative cysteines are predicted in the coding sequence. “location” indicates the predicted location in the channel subunit.
“after” or “before” the membrane domain (S or M) indicates palmitoylated cysteine within 10 amino acids of a membrane domain. SV, splice variant.
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eral recent freely available predictive tools have proved suc-
cessful in characterizing potential new palmitoylation targets
(e.g. Refs. 67 and 68). For example, the multi-platform CSS-
Palm 2.0 tool (67) exploits a clustering and scoring strategy by
comparing the surrounding amino acid sequence similarity
with that of a set of340 experimentally determined palmi-
toylation sites. CSS-Palm predicts75% of the experimen-
tally identified ion channel palmitoylation sites (Tables 1–3)
and suggests that50% of human channel subunits may be
palmitoylated.3 Recent advances in biochemical analysis of
palmitoylation should facilitate testing of this latter
prediction.
Biochemical Identification of Protein Palmitoylation
Metabolic Labeling (Palmitate-centric Assays)—Tradition-
ally, protein palmitoylation has been characterized using met-
abolic labeling of cells with radioactive palmitate (e.g.
[3H]palmitate) and subsequent immunoprecipitation and
identification of candidate proteins by autoradiography/fluo-
rography. However, this approach typically requires extensive
(several weeks) exposure of autoradiographs and is not readily
amenable for global analysis to enrich and identify palmitoy-
lated proteins (7, 69, 70). The recent development of
biorthogonal lipid probes (for review, see Ref. 7), modified
fatty acids with reactive groups such as an azide or alkyne
group, allows labeled proteins to be conjugated to biotin or
fluorophores via the azide or alkyne group using Staudinger
ligation or “click” chemistry. In particular, the development of
a family of -alkynyl fatty acid probes of different chain
lengths (such as Alk-C16 and Alk-C18) has been exploited for
proteomics profiling or cellular imaging and has identified
candidate palmitoylated channels in a number of mammalian
cell lines (71–75). Although such metabolic labeling ap-
proaches are most suited to analysis of isolated cells rather
than tissues, they can provide information on dynamic palmi-
toylation of proteins during the labeling period.
Cysteine Accessibility Assays (Cysteine-centric Assays) and
Acyl-biotin Exchange (ABE)—By coupling hydroxylamine
cleavage (at neutral pH) of the cysteine-palmitoyl thioester
linkage with subsequent labeling of the newly exposed cysteine
thiol with cysteine-reactive biotin groups (such as 1-biotin-
amido-4-(4-(maleimidoethylcyclohexane)carboxamido)-
butane or N-(6-(biotinamido)hexyl)-3-(2-pyridyldithio)-
propionamide), S-acylated proteins can be specifically labeled
with biotin and can thus be purified and subsequently identi-
fied by mass spectrometry (69, 76–78). This unique approach
allows S-acylation of native endogenous proteins to be
assayed without the requirement for prior cell isolation and
metabolic labeling. The ABE approach has been exploited to
determine the “palmitoylome” in a number of species (78, 79),
although it must be remembered that it detects S-acylation
and does not define palmitoylation per se. In particular, analy-
sis of rat brain identified both previously characterized as well
as novel palmitoylated ion channels (Tables 1–3). The ABE
approach determines the net amount of pre-existing S-acy-
lated proteins; however, caution is required to eliminate false
positives, in particular, the requirement to fully block all reac-
tive cysteines prior to hydroxylamine cleavage. A recent
development of this approach, exploiting resin-assisted cap-
ture using thiopropyl-Sepharose instead of biotin analogs, has
been reported to improve detection of higher molecular
weight palmitoylated proteins (80) and thus may prove valua-
ble for ion channel analysis.
The metabolic labeling and ABE methodologies are thus
complementary, and exploitation of these approaches should
provide very significant insight into the role and regulation of
ion channel palmitoylation. However, it is important to note
that palmitic acid can also be incorporated into free N-termi-
nal cysteines of proteins via an amide linkage (N-palmitoyla-
tion) or the addition of the monounsaturated palmitoleic acid
via an oxyester linkage to a serine residue (7, 9). Furthermore,
although these modifications can be discriminated by their
insensitivity to hydroxylamine cleavage of the S-palmitoyla-
tion thioester linkage, other S-linked fatty acids such as
arachidonic, oleate, and stearic acids have also been reported
(7, 9). Thus, whether other S-linked fatty acids and/or N- or
O-linked palmitoylation controls ion channel function re-
mains to be explored. In most cases, candidate palmitoylated
cysteine residues have been characterized using mutagenic
strategies combined with ABE or [3H]palmitate incorporation
assays to screen for loss of palmitoylation. As such, direct bio-
chemical demonstration of native cysteine palmitoylation (e.g.
using mass spectrometry) is lacking in most ion channels (and
other proteins).3 M. J. Shipston, unpublished data.
TABLE 3
Other channels identified in mammalian palmitoylome screens
The channels listed were identified in S-acylation screens from rat brain (79),
Jurkat cells (73, 85), dendritic cells (75), and prostate cancer cells (86) and are not
independently characterized as in Tables 1 and 2. Common channel and gene
names are given. Y indicates that at least one cysteine is predicted with the CSS-
Palm 2.04 algorithm (67) at high threshold using the corresponding NCBI
accession number of the full-length murine channel-coding sequence (also
validated for cognate species used in reference). N indicates that cysteines in the
coding region are not predicted.
Channel Gene CSS-Palm Accession no.
Anion
Chloride channel 6 Clcn6 Y NM_008166
Chloride intracellular channel 1 Clic1 N NM_033444
Chloride intracellular channel 4 Clic4 N NM_013885
Tweety homolog 1 Ttyh1 Y NM_001001454
Tweety homolog 3 Ttyh3 Y NM_175274
Voltage-dependent anion channel 1 Vdac1 N NM_011694
Voltage-dependent anion channel 2 Vdac2 Y NM_011695
Voltage-dependent anion channel 3 Vdac3 Y NM_001198998
Calcium
Voltage-dependent, gamma subunit 8 Cacng8 Y NM_133190
Cation
Amiloride-sensitive cation channel 2 Accn2 Y NM_009597
Glutamate
Ionotropic, delta 1 Grid1 Y NM_008166
Perforin
Perforin-1 Prf1 Y NM_011073
Potassium




Voltage-gated, type I, alpha Scn1a Y NM_018733
Voltage-gated, type III, alpha Scn3a Y NM_018732
Voltage-gated, type IX, alpha Scn9a Y NM_018852
Transient receptor potential
Cation channel, subfamily V, member 2 Trpv2 N NM_011706
Cation channel, subfamily M, member 7 Trpm7 Y NM_021450
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Genetic Manipulation of zDHHCs and Thioesterases
With the identification of the family of palmitoyl acyltrans-
ferases, genetic tools have been exploited to identify candidate
zDHHCs that control channel palmitoylation and function.
To date, most studies have exploited overexpression of candi-
date zDHHCs and analyzed increases in [3H]palmitate incor-
poration to define zDHHC channel specificity (e.g. see Refs.
22, 23, and 28). Although this is a powerful approach, caution
is required to determine whether this in fact replicates endog-
enous regulation. For example, overexpression of some
zDHHCs results in palmitoylation of a cysteine residue not
endogenously palmitoylated in BK channels when expressed
in HEK293 cells (51). Few studies have exploited knockdown
of endogenous zDHHCs to interrogate palmitoylation of ion
channels by native zDHHCs, although such an approach al-
lowed the first systematic characterization of zDHHCs re-
quired for palmitoylation of any ion channel (51). This ap-
proach revealed that multiple distinct zDHHCs control
palmitoylation of the BK channel C terminus. As some
zDHHCs are themselves palmitoylated, the functional ef-
fect of overexpressing or knocking down individual
zDHHCs on the localization and activity of other zDHHCs
needs to be determined. Furthermore, as many signaling
and cytoskeletal elements are controlled by palmitoylation,
direct effects on channel palmitoylation per se need to be
evaluated.
Pharmacological Manipulation of Palmitoylation
The most widely employed S-acylation inhibitor for cellular
studies is the palmitate analog 2-bromopalmitate (81). How-
ever, 2-bromopalmitate does not display selectivity toward
specific zDHHC proteins (82), and at high concentrations,
this compound has many pleiotropic effects on cells, includ-
ing cytotoxicity (81). Other less commonly used inhibitors
include cerulenin and tunicamycin; however, cerulenin affects
many aspects of lipid metabolism (81), and tunicamycin is an
established inhibitor of N-linked glycosylation (81). There are
no known specific activators of zDHHCs. In contrast to the
lack of pharmacological tools for zDHHCs, small molecule
inhibitors of the major cytosolic acyl thioesterase APT1 (66)
have been developed, although, to date, these have not been
exploited to interrogate ion channel depalmitoylation.
Clearly, a major goal for the field is to identify novel S-acyla-
tion inhibitors that display both specificity and zDHHC selec-
tivity (76, 82, 83).
Conclusions and Perspectives
The last 5 years have seen a major resurgence in the protein
palmitoylation field due, in large part, to the development of
new proteomics tools and characterization of the major
palmitoylating enzymes. To date,40 different ion channel
subunits have been shown experimentally to be S-acylated,
and the development of new tools is now beginning to reveal
both mechanistic and functional insights into the effect
palmitoylation exerts on these important signaling molecules.
Although it is fully expected that the ion channel palmitoy-
lation “catalog” will grow significantly in the next few years,
the goal of the field must be to develop fundamental under-
standing of the mechanistic role of palmitoylation in control-
ling diverse aspects of ion channel properties and function.
Furthermore, a major goal is to elucidate the physiological
consequence of ion channel palmitoylation from the single
channel to body systems level. Several major challenges and
questions must be addressed if we are to tackle these aims,
elucidation of which will have major impacts on both the ion
channel and wider signaling fields.
The first challenge is the development of improved tools to
allow real-time analysis of the palmitoylation status of ion
channels and analysis of channel palmitoylation from the sin-
gle molecule to cellular and tissue function. This includes the
development of selective inhibitors (76, 82, 83) and/or activa-
tors of zDHHCs combined with improved proteomics tools
(e.g. palmitoylation-specific antibodies) and imaging probes.
Second, although palmitoylation is widely accepted to be re-
versible, the spatiotemporal regulation of palmitoylation on
any channel is very poorly understood. Imperative in this re-
gard is understanding the physiological and pathological sig-
nals that can regulate the activity and localization of the
palmitoylating and depalmitoylating enzymes. Furthermore,
mechanistic insight into the target selectivity of zDHHCs will
allow us to understand the coordinated regulation of ion
channels by palmitoylation signaling cascades and to decipher
how distinct domains on the same channel may be differen-
tially regulated by palmitoylation. Third, for most ion chan-
nels, the mechanism by which palmitoylation modifies traf-
ficking, gating, or regulation is unknown, although it is widely
assumed that effects are determined by a simple “membrane
anchor” model. Obtaining structural insights into how palmi-
toylation controls protein architecture, interactions, and
properties will be a major challenge. Fourth, as with any PTM,
palmitoylation cannot be considered in isolation. Clear evi-
dence from the ion channel field demonstrates significant
levels of functional cross-talk of palmitoylation with other
major signaling pathways, including phosphorylation. Mecha-
nistic insight into the fundamental rules controlling palmitoy-
lation cross-talk will have an enormous impact far beyond the
realms of ion channel biology. Finally, although an increasing
number of ion channels are known to be regulated by palmi-
toylation, very little is known about the functional conse-
quence at the cellular and organismal levels. Although it is
clear that disruption of palmitoylation can lead to major dis-
orders, ranging from cancer to affective disorders, the impor-
tance of ion channel palmitoylation in (patho)physiology is
largely unexplored. For example, will we begin to uncover
channel “palmitoylopathies” that result from dysregulation of
ion channel palmitoylation analogous to channel phosphory-
lopathies (84) that have been discovered? Understanding the
control and functional consequence of ion channel palmitoy-
lation from the level of the single channel to the whole orga-
nism may lead to novel therapeutic strategies to control di-
verse physiological processes. The next few years represent a
challenging and exciting time that promises to reveal funda-
mental new insights into both ion channel physiology and
protein palmitoylation.
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